Delivery Order SPE2DB24D2010-SPE2DB24FZTF1
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,603,841 units of epinephrine 0.3 mg auto-injector 2-packs. The $47,777.78 contract has a completion date of May 15, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,556,651 units of 0.3 mg epinephrine auto-injectors. The $2,903.70 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,259,971 units of Epinephrine 0.3 mg auto-injector 2-packs. The $1,068.63 contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, that...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,547,771 units of Epinephrine 0.3 mg auto-injectors. The contract has a potential value of $2,708.88 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,096.56 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,261,488 units of 0.3 mg epinephrine auto-injectors. The award is a standalone delivery order under DLA's primary contract vehicle with AmerisourceBergen, an indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 and a period of performance through December 31, 2025. This IDC enables...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,205,068 units of epinephrine 0.15 mg auto-injectors. The $1,298.67 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA with a potential value of up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,881,870 epinephrine 0.3 mg auto-injectors. The contract has a potential value of $1,205.64 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,900,396 units of the Epinephrine 0.3 mg auto-injector product. The $1,688.23 contract has a performance period through March 11, 2024 and does not have a set-aside designation. This award is issued under an existing indefinite delivery contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,833.96 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,097,693 units of epinephrine 0.3 mg auto-injectors. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZTF1Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,184,277 units of Epinephrine 0.3 mg auto-injectors. The $11,219.50 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order is not designated as a set-aside.
Generated 7/5/24, 9:31 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 4/5/24 |